Concerning the RAD52 gene, a study published by Shi et al. analyzed three RAD52 SNPs with potential functional effect and evaluated, in an in vitro model, their association with platinum resistance and clinical outcome in cervical squamous cell carcinoma (CSCC) patients [61]. The gene discussed is RAD52; the disease is skin squamous cell carcinoma.